Mid-Atlantic Bio Therapeutics
Mid-Atlantic Bio Therapeutics (MABT) is a pharmaceutical company based in Doylestown, PA, founded in 2011 with a mission to eradicate life-threatening infectious diseases using their proprietary therapy technology, IMT504. Specializing in immunotherapy for infectious diseases, MABT is actively developing next-generation COVID-19 vaccines and focusing on a medical breakthrough for Rabies treatment.
Led by a team of experienced professionals in infectious diseases, research, and business development, MABT is at the forefront of creating innovative treatment paradigms for viral diseases. With a focus on revolutionizing medical care through immunotherapy, MABT aims to address critical global health challenges and provide effective solutions for unmet medical needs.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
